The present application relates to a novel tetrahydroquinoline derivative, to a process for its preparation, to its use on its own or in combination for treating and/or preventing diseases and to its use for preparing medicaments, in particular as an inhibitor of the cholesterol ester transfer protein (CETP) for the treatment and/or prevention of cardiovascular disorders, in particular hypolipoproteinaemias, dyslipidaemias, hypertriglyceridaemias, hyperlipidaemias, hypercholesterolaemias and arteriosclerosis.

Claims

9 · 5 independent · depth 3

9 granted claims

›1.independentA compound of the formula (I)

›2.independentA compound of the formula (Ia)+2

›3.independentA compound of the formula (Ib)+2

›4.independentmultiple · 1, 2, 3A pharmaceutical composition comprising the compound of the formula (I) as defined in any of claims 1 to 3 in combination with an inert nontoxic pharm…

›5.independentmultiple · 1, 2, 3A pharmaceutical composition comprising the compound of the formula (I) as defined in any of claims 1 to 3 in combination with one or more further act…

Classifications

3 codes

IPC · International Patent Classification

Section C — Chemistry; metallurgy

C07D215/38

USPC · US Patent Classification

546/168546/167

Claim changes

Soon

Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this patent are not paired with the granted ones in what we hold.

File wrapper

⤢ drag to zoom

USPTOApplicanthover for detail · click to open

Pendency

5.8 y

2,133 days filing → grant

Office actions

non-final + final

Responses

2 RCE

Examiner

D M Seaman

art unit 1625 · TC 1600

Law firm

Law firm · Log in to unlock

Citations: 19 back · 0 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Term & fees

See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.

Priority chain

1 priority documents

›Priority documents — 1

Type	Document	Date
related publication	US 20080255068 A1	16 Oct 2008

Validity challenges

See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.

Citations

See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.